AU7217891A - Therapeutic agents, and intermediates for the synthesis thereof - Google Patents
Therapeutic agents, and intermediates for the synthesis thereofInfo
- Publication number
- AU7217891A AU7217891A AU72178/91A AU7217891A AU7217891A AU 7217891 A AU7217891 A AU 7217891A AU 72178/91 A AU72178/91 A AU 72178/91A AU 7217891 A AU7217891 A AU 7217891A AU 7217891 A AU7217891 A AU 7217891A
- Authority
- AU
- Australia
- Prior art keywords
- intermediates
- synthesis
- therapeutic agents
- therapeutic
- agents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/642—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the peptide or protein in the drug conjugate being a cytokine, e.g. IL2, chemokine, growth factors or interferons being the inactive part of the conjugate
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB909003257A GB9003257D0 (en) | 1990-02-13 | 1990-02-13 | Therapeutic agents and intermediates for the synthesis thereof |
GB9003257 | 1990-02-13 | ||
GB909006500A GB9006500D0 (en) | 1990-03-23 | 1990-03-23 | Therapeutic agents,and intermediates for the synthesis thereof |
GB9006500 | 1990-03-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU7217891A true AU7217891A (en) | 1991-09-03 |
Family
ID=26296657
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU72178/91A Abandoned AU7217891A (en) | 1990-02-13 | 1991-02-13 | Therapeutic agents, and intermediates for the synthesis thereof |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU7217891A (en) |
WO (1) | WO1991012021A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2329768C (en) * | 1998-04-27 | 2008-06-10 | Opperbas Holding B.V. | Pharmaceutical composition comprising factor viii and neutral liposomes |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3855869T2 (en) * | 1987-02-20 | 1997-10-02 | Genentech Inc | Methods and preparations for the use of HIV env polypeptides and antibodies |
NZ226414A (en) * | 1987-10-02 | 1992-07-28 | Genentech Inc | Cd4 peptide adhesion variants and their preparation and use |
ZA893284B (en) * | 1988-05-04 | 1990-03-28 | Igen Inc | Peptide analogs and their use as haptens to elicit catalytic antibodies |
CA2051107A1 (en) * | 1989-04-25 | 1990-10-26 | William N. Sun | Antibodies specific for cd4-binding domain of hiv |
-
1991
- 1991-02-13 WO PCT/GB1991/000215 patent/WO1991012021A2/en unknown
- 1991-02-13 AU AU72178/91A patent/AU7217891A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1991012021A3 (en) | 1991-12-12 |
WO1991012021A2 (en) | 1991-08-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU656157B2 (en) | Pharmaceutical agents | |
AU7122291A (en) | 3-arylcarbonyl-1h-indoles useful as therapeutic agents | |
AU3599393A (en) | Portable spirometer | |
AU9089591A (en) | Inhaler | |
AU3888793A (en) | Novel medicament | |
AU8751391A (en) | Inhaler | |
HU9302460D0 (en) | 5/20/4-(1,2-benzisothiazole-3-yl)-1-pierazinyl/ethyl/-6-chlorine-1,3-dihydro-2h-indole-2-one-hydrogen-chloride-mononhydrate | |
AU2805195A (en) | Therapeutic compounds | |
AU3284395A (en) | Synthesis of 1,1,1,3,3,-pentafluoropropane | |
AU8043491A (en) | Fungicides | |
AU7957791A (en) | Portable golf-sack | |
AU8212891A (en) | Equine herpesvirus-4 tk-vaccine | |
AU1140197A (en) | Pyridyl carbamates, process and intermediates for the preparation and use thereof | |
AU3263493A (en) | Tonometer | |
AU639825B2 (en) | Substituted 1,2,4-triazinediones, processes for their preparation, intermediates therefor and their use | |
AU7719791A (en) | Therapeutic product | |
AU2547895A (en) | Therapeutic phenoxyalkylheterocycles | |
AU5371694A (en) | Use of the tarchonanthus camphoratus | |
EP0445827A3 (en) | 4-hydroxytetrahydropyran-2-one derivatives and intermediates for synthesizing the same | |
AU6594690A (en) | Therapeutic agents | |
AU2402392A (en) | New anti-diarrheic agents | |
AU7217891A (en) | Therapeutic agents, and intermediates for the synthesis thereof | |
AU4762993A (en) | Keratometer | |
AU7442791A (en) | Massage arrangement | |
AU8043891A (en) | Fungicides |